Skip to main content
. 2020 Oct 29;6:77. doi: 10.1038/s41421-020-00221-6

Fig. 2. Clinical indices between the use of antihypertensive agents and no use among total cohorts and a subgroup of patients older than 65 years with hypertension comorbidity.

Fig. 2

a Lymphocyte counts, hemoglobin, C-reactive protein, procalcitonin, and D-dimer expression levels of COVID-19 patients between ARB users and no-use antihypertensive agents. b Hemoglobin expression levels of COVID-19 patients between used thiazide diuretics and no-use antihypertensive agents. c Lymphocyte counts, percentages, and hematocrit expression levels of COVID-19 patients between used BB and no-use antihypertensive agents. d Lymphocyte and basophilic granulocyte count expression levels of COVID-19 patients between CCB users and no-use antihypertensive agents, among the total cohort and older than 65-year cohort with hypertension comorbidity. Boxplots with all points are shown in the graph. *P value < 0.05, **P value < 0.01, Mann–Whitney U test. Detailed available numbers of each laboratory result group are shown in Supplementary Table S5.